RecruitingNot ApplicableNCT05422248

Oxygen Wound Therapy Feasibility Study


Sponsor

Fisher and Paykel Healthcare

Enrollment

10 participants

Start Date

Dec 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Determine the feasibility of using a new topical oxygen therapy device to treat hard to heal lower leg wounds.


Eligibility

Min Age: 16 Years

Inclusion Criteria4

  • Patients with hard to heal lower leg wounds as determined by the treating clinician.
  • Patient has a wound area greater than the area of the interface
  • Aged 16 years and over
  • Able to provide informed consent

Exclusion Criteria5

  • Lower limb wounds with bone or tendon exposed
  • Infected wounds which require treatment with antibiotics
  • Wounds with critical bioburden requiring a medicated dressing
  • Wounds that require dressing changes more than every second day, for example high exudating wounds
  • Wounds with slough covering more than 30% of the wound surface

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESeries Topical Oxygen Therapy

Standard care provided to the whole wound followed by intervention device care to the whole wound.

DEVICEPaired Topical Oxygen Therapy

Care provided to one portion of wound by intervention device and standard care to remaining portion of wound.


Locations(1)

Otago Vascular Diagnostics

Dunedin, Otago, New Zealand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05422248


Related Trials